NCT07169617 2026-03-18Testing the SurVaxM Vaccine for Lung Cancer PreventionNational Cancer Institute (NCI)Phase 2 Not yet recruiting80 enrolled
NCT00020267 2024-03-04Vaccine Therapy in Treating Patients With Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed